Comment on “Serious infections among a large cohort of subjects with systemically treated psoriasis” - 19/04/18
Doi : 10.1016/j.jaad.2017.10.054
David L. Arnold, BS a, Steven R. Feldman, MD, PhD a, b, c, ⁎ 
a Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina
b Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina
c Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina
∗Correspondence to: Steven R. Feldman, MD, PhD, Department of Dermatology, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1071Department of DermatologyWake Forest School of MedicineMedical Center BlvdWinston-SalemNC27157-1071
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflicts of interest: Dr Feldman has received research, speaking, and/or consulting support from a variety of companies including Galderma, GSK/Stiefel, Almirall, Leo Pharma, Baxter, Boeringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Taro, Abbvie, Cosmederm, Anacor, Astellas, Janssen, Lilly, Merck, Merz, Novartis, Regeneron, Sanofi, Novan, Parion, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate, and National Psoriasis Foundation. He is founder and majority owner of www.DrScore.com and founder and part owner of Causa Research, a company dedicated to enhancing patients' adherence to treatment. Mr Arnold has no conflicts to conflicts to disclose. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 78 - N° 5
P. e113-e114 - mai 2018 Retour au numéro
Article précédent
- The use of the vessel loop to bolster mattress sutures and prevent scars
- Paula Molés-Poveda, Begoña Escutia-Muñoz, Anaid Calle, Rafael Botella-Estrada
- Reply to: Comment on “Serious infections among a large cohort of subjects with systemically treated psoriasis”
- Allison S. Dobry, Charles P. Quesenberry, Maryam M. Asgari
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?